SCHEMBL3354763

SCHEMBL3354763

O=[N+]([O-])c1ccc2c(ccn2C2CCNCC2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
SLC6A4 P31645 1/20 0.42
CYP2C19 P33261 1/20 0.42
THPO P40225 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
SLC6A2 P23975 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.41
ADRB1 P08588 1/20 0.39
SIRT6 Q8N6T7 1/20 0.39
KRAS P01116 1/20 0.38
ADRA2A P08913 1/20 0.38
PNMT P11086 1/20 0.38
GABRA1 P14867 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3353782 0.89 ALDH1A1 (0.42) HTR3EHTR3BALDH1A1CYP1A2CYP3A4
SCHEMBL13537408 0.86 KDM4C (0.42) SLC6A4SLC6A2KDM4C
SCHEMBL31735651 0.86 CHRNB4 (0.44) HTR3EHTR3BALDH1A1CYP1A2CYP3A4
SCHEMBL3354240 0.83 HTR7 (0.45) ALDH1A1SLC6A4SLC6A2SIRT6
SCHEMBL29263697 0.81 SLC6A2 (0.44) ALDH1A1CYP1A2SLC6A2SIRT2KRAS
SCHEMBL31036118 0.81 SLC6A2 (0.44) ALDH1A1CYP1A2SLC6A2SIRT2KRAS
SCHEMBL23902708 0.81 SLC6A2 (0.40) ALDH1A1SLC6A2SIRT2KRASADRA2A
SCHEMBL1865868 0.80 KRAS (0.41) ALDH1A1CYP1A2SLC6A2KRAS
SCHEMBL13537503 0.80 MEN1 (0.42) ALDH1A1SLC6A4SLC6A2SIRT2KRAS
SCHEMBL31735701 0.80 SLC6A2 (0.43) ALDH1A1CYP1A2SLC6A2SIRT2SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed